Skip to content

Sanara MedTech Inc. SMTI Accretion Of Finance Liabilities

Accretion Of Finance Liabilities at other companies

InvenTrust Properties logo
InvenTrust PropertiesIVT
$27.25K
SLD
Solid PowerSLDP
$17K+6.3%
Jones Lang LaSalle logo
Jones Lang LaSalleJLL
$1.4M-17.6%
Boston Omaha logo
Boston OmahaBOC
$55K+1.9%
Proto Labs logo
Proto LabsPRLB
$3K-50.0%
Profound Medical logo
Profound MedicalPROF
$5K-89.6%

Other financials

Income statement

See full
Revenue$27.8M+18.6%
Gross profit$25.9M+19.8%
Operating income$2.6M+221%
Net income$459.0K+113%
EPS (diluted)$0.05+112%

Balance sheet

See full
Cash & equivalents$13.6M-34.3%
Total debt$48.4M+8.2%
Total equity$7.0M-80.8%
Total assets$69.3M-28.1%

Cash flow

See full
Operating cash flow-$2.5M-23.3%
CapEx$43.8K-97.5%
Free cash flow-$2.5M+32.6%

Valuation

See full
Market cap$216.18M-9.7%
Enterprise value$250.95M-6.5%
P/S-0.5×

Profitability

See full
Gross margin92.9%+1.8pp
Operating margin6.1%+5.1pp
Net margin-31.2%-93.4pp
FCF margin-9.8%-3.5pp

Returns & leverage

See full
Return on equity-153.7%-199pp
Debt / equity6.9×+5.7×
Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept SMTI:AccretionOfFinanceLiabilities.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s accretion of finance liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sanara MedTech Inc.'s accretion of finance liabilities?
Sanara MedTech Inc. (SMTI) reported accretion of finance liabilities of $27.11K in Q1 2026.
How has Sanara MedTech Inc.'s accretion of finance liabilities changed year-over-year?
Sanara MedTech Inc.'s accretion of finance liabilities decreased by 37.9% year-over-year, from $43.63K to $27.11K.
What does accretion of finance liabilities mean?
The non-cash increase in the carrying value of financial liabilities over time, typically related to the unwinding of discounts on long-term debt or earn-out obligations. It reflects the effective interest expense recognized as the liability approaches its maturity or settlement value.